Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126013661 | 12601366 | 1 | I | 0 | 20160727 | 20160727 | DIR | 77.00 | YR | M | N | 0.00000 | 20160726 | N | PH | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126013661 | 12601366 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Oral | D | D | 0 | 2 | DF | COATED TABLET | QD | |||||
126013661 | 12601366 | 2 | SS | TRACLEER | BOSENTAN | 1 | Oral | D | D | 0 | 1 | DF | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126013661 | 12601366 | 1 | Pulmonary hypertension |
126013661 | 12601366 | 2 | Pulmonary hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126013661 | 12601366 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126013661 | 12601366 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
126013661 | 12601366 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126013661 | 12601366 | 1 | 20150726 | 20160503 | 0 | |
126013661 | 12601366 | 2 | 20150722 | 20160531 | 0 |